RU2020134037A - Способы скрининга субъекта на риск развития хронической болезни почек и компьютерно-реализуемый способ - Google Patents

Способы скрининга субъекта на риск развития хронической болезни почек и компьютерно-реализуемый способ Download PDF

Info

Publication number
RU2020134037A
RU2020134037A RU2020134037A RU2020134037A RU2020134037A RU 2020134037 A RU2020134037 A RU 2020134037A RU 2020134037 A RU2020134037 A RU 2020134037A RU 2020134037 A RU2020134037 A RU 2020134037A RU 2020134037 A RU2020134037 A RU 2020134037A
Authority
RU
Russia
Prior art keywords
measured
subject
albumin
level
creatinine
Prior art date
Application number
RU2020134037A
Other languages
English (en)
Russian (ru)
Inventor
Александер БЮССЕР
Тони ХУШТО
Вольфганг ПЕТРИХ
Штефан РАВИЦЦА
Бернд ШНАЙДИНГЕР
Original Assignee
Ф. Хоффманн-Ля Рош Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP18163573.1A external-priority patent/EP3543702B1/en
Application filed by Ф. Хоффманн-Ля Рош Аг filed Critical Ф. Хоффманн-Ля Рош Аг
Publication of RU2020134037A publication Critical patent/RU2020134037A/ru

Links

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06NCOMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00Computing arrangements based on biological models
    • G06N3/02Neural networks
    • G06N3/08Learning methods
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/34Genitourinary disorders
    • G01N2800/347Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/54Determining the risk of relapse
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Data Mining & Analysis (AREA)
  • Pathology (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Databases & Information Systems (AREA)
  • Theoretical Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Artificial Intelligence (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Software Systems (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Mathematical Physics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Computational Linguistics (AREA)
  • General Engineering & Computer Science (AREA)
  • Computing Systems (AREA)
RU2020134037A 2018-03-23 2019-03-22 Способы скрининга субъекта на риск развития хронической болезни почек и компьютерно-реализуемый способ RU2020134037A (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP18163573.1A EP3543702B1 (en) 2018-03-23 2018-03-23 Methods for screening a subject for the risk of chronic kidney disease and computer-implemented method
EP18163573.1 2018-03-23
EP19150615 2019-01-07
EP19150615.3 2019-01-07
PCT/EP2019/057297 WO2019180232A1 (en) 2018-03-23 2019-03-22 Methods for screening a subject for the risk of chronic kidney disease and computer-implemented method

Publications (1)

Publication Number Publication Date
RU2020134037A true RU2020134037A (ru) 2022-04-26

Family

ID=65802112

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2020134037A RU2020134037A (ru) 2018-03-23 2019-03-22 Способы скрининга субъекта на риск развития хронической болезни почек и компьютерно-реализуемый способ

Country Status (10)

Country Link
US (1) US20210118570A1 (ko)
EP (1) EP3769086A1 (ko)
KR (1) KR20200135444A (ko)
CN (1) CN112105933A (ko)
AU (1) AU2019238388A1 (ko)
BR (1) BR112020019087A2 (ko)
CA (1) CA3094294A1 (ko)
MX (1) MX2020009705A (ko)
RU (1) RU2020134037A (ko)
WO (1) WO2019180232A1 (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4060347A1 (en) * 2021-03-15 2022-09-21 F. Hoffmann-La Roche AG Method for screening a subject for the risk of chronic kidney disease and computer-implemented method
CN115148375B (zh) * 2022-08-31 2022-11-15 之江实验室 一种高通量真实世界药物有效性与安全性评价方法及系统
CN117711619A (zh) * 2023-12-15 2024-03-15 南方医科大学南方医院 一种糖尿病患者慢性肾脏病发生风险预测系统及存储介质

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201214440D0 (en) * 2012-08-13 2012-09-26 Randox Lab Ltd Kidney disease biomarker
EP2746769A1 (en) * 2012-12-21 2014-06-25 Stembios Technologies, Inc. Method for evaluating effect of action on subject based on stem celldynamics
GB201404789D0 (en) * 2014-03-18 2014-04-30 Univ Dundee Biomarkers
RU2733471C2 (ru) * 2015-04-24 2020-10-01 Сфинготек Гмбх Способ прогнозирования риска развития хронического заболевания почек

Also Published As

Publication number Publication date
US20210118570A1 (en) 2021-04-22
BR112020019087A2 (pt) 2020-12-29
EP3769086A1 (en) 2021-01-27
AU2019238388A1 (en) 2020-10-15
MX2020009705A (es) 2020-10-07
WO2019180232A1 (en) 2019-09-26
CN112105933A (zh) 2020-12-18
KR20200135444A (ko) 2020-12-02
CA3094294A1 (en) 2019-09-26

Similar Documents

Publication Publication Date Title
RU2020134037A (ru) Способы скрининга субъекта на риск развития хронической болезни почек и компьютерно-реализуемый способ
Somsouk et al. Moderate ascites identifies patients with low model for end‐stage liver disease scores awaiting liver transplantation who have a high mortality risk
Horio et al. Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates
CN110428901B (zh) 脑卒中发病风险预测系统及应用
RU2015136919A (ru) Отслеживание изменений усредненных значений гликемии у диабетиков
AU2014289978A1 (en) Quantifying a blood vessel reflection parameter of the retina
Ćulafić et al. Role of cystatin C and renal resistive index in assessment of renal function in patients with liver cirrhosis
Sinning et al. Association of high-sensitivity assayed troponin I with cardiovascular phenotypes in the general population: the population-based Gutenberg health study
ES2685395T3 (es) Método para proporcionar pruebas diagnósticas no invasivas confiables
Cogswell et al. A novel model incorporating pectoralis muscle measures to predict mortality after ventricular assist device implantation
Besachio et al. Noncontrast computed tomographic Hounsfield unit evaluation of cerebral venous thrombosis: a quantitative evaluation
JP5774993B2 (ja) 肢切断患者の補正容積区画を量定する方法並びにこの方法を実施する装置及びコンピュータプログラム製品
JP2013504766A5 (ko)
JP2018529931A5 (ko)
EP3894852A1 (en) Biomarker combinations in ex vivo lung perfusion (evlp) perfusate
JP2019531261A5 (ko)
Assadi The growing epidemic of chronic kidney disease: preventive strategies to delay the risk for progression to ESRD
Suebmee et al. Correlation of glomerular filtration rate between renal scan and estimation equation for patients with scleroderma
FI3543702T3 (fi) Menetelmiä koehenkilön kroonisen munuaissairauden riskin seulomiseksi ja tietokoneella toteutettu menetelmä
JP6727660B2 (ja) 糖尿病性腎症の判定マーカー
RU2641843C2 (ru) Способ прогнозирования риска смерти больных с острой декомпенсацией хронической сердечной недостаточности
US8055051B2 (en) Method and system for selecting the number of gaussian modes for the segmentation of cardiac magnetic resonance (MR) images
Dimiati et al. Study of NT-proBNP and Hs-Troponin I biomarkers for early detection of children’s heart function of proteinenergy malnutrition
Hori et al. Evaluation of Preoperative Abdominal Adipose Tissue–, Inflammation-, Muscle Mass–, and Nutritional Status–based Prognostic Markers to Assess Renal Dysfunction in Living Kidney Donors
Jansen et al. Change of Left Ventricular Myocardial Contractility in Speckle Tracking Echocardiography After Transjugular Intrahepatic Portosystemic Shunt Predicts Survival